NL
CLX icon

NorthAvenue LLC’s Clorox CLX Stock Holding History

NorthAvenue LLC’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$605 – 291
2025
Q4 		$605 Buy
+6
New +$651 ﹤0.01% 247

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

NorthAvenue LLC's CLX Position: Q1 2026 in Review

NorthAvenue LLC sold out of Clorox (CLX) in Q1 2026, closing a stake of 6 shares — an estimated $605 sold.

NorthAvenue LLC first reported a position in CLX in Q4 2025 and held it in 1 quarter. The position peaked at $605 in Q4 2025. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • NorthAvenue LLC reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • NorthAvenue LLC sold 6 Clorox shares in Q1 2026, an estimated $605.
  • NorthAvenue LLC first reported a position in Clorox in Q4 2025 and held it in 1 quarter.
  • NorthAvenue LLC's Clorox position peaked at $605 in Q4 2025.
  • 1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on NorthAvenue LLC's 13F filing for Q1 2026, filed 15 Apr 2026.